Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Maija Lappalainen and Olli Vapalahti.
Maija Lappalainen
Connection Strength
0.720
Olli Vapalahti
  1. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation. J Clin Virol. 2020 08; 129:104512.
    View in: PubMed
    Score: 0.222
  2. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Euro Surveill. 2020 05; 25(18).
    View in: PubMed
    Score: 0.220
  3. Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients. PLoS One. 2021; 16(5):e0251661.
    View in: PubMed
    Score: 0.059
  4. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021 04; 137:104785.
    View in: PubMed
    Score: 0.058
  5. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Travel Med Infect Dis. 2021 Jan-Feb; 39:101949.
    View in: PubMed
    Score: 0.057
  6. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. 2020 03; 25(11).
    View in: PubMed
    Score: 0.054
  7. Validation of serological and molecular methods for diagnosis of zika virus infections. J Virol Methods. 2019 01; 263:68-74.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.